274 related articles for article (PubMed ID: 17416474)
1. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
Rejali D; Lee VA; Abrashkin KA; Humayun N; Swiderski DL; Raphael Y
Hear Res; 2007 Jun; 228(1-2):180-7. PubMed ID: 17416474
[TBL] [Abstract][Full Text] [Related]
2. Stable release of BDNF from the fibroblast cell line NIH3T3 grown on silicone elastomers enhances survival of spiral ganglion cells in vitro and in vivo.
Warnecke A; Sasse S; Wenzel GI; Hoffmann A; Gross G; Paasche G; Scheper V; Reich U; Esser KH; Lenarz T; Stöver T; Wissel K
Hear Res; 2012 Jul; 289(1-2):86-97. PubMed ID: 22564255
[TBL] [Abstract][Full Text] [Related]
3. Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy.
Takada Y; Beyer LA; Swiderski DL; O'Neal AL; Prieskorn DM; Shivatzki S; Avraham KB; Raphael Y
Hear Res; 2014 Mar; 309():124-35. PubMed ID: 24333301
[TBL] [Abstract][Full Text] [Related]
4. The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection.
Wise AK; Tu T; Atkinson PJ; Flynn BO; Sgro BE; Hume C; O'Leary SJ; Shepherd RK; Richardson RT
Hear Res; 2011 Aug; 278(1-2):69-76. PubMed ID: 21557994
[TBL] [Abstract][Full Text] [Related]
5. Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment.
Landry TG; Wise AK; Fallon JB; Shepherd RK
Hear Res; 2011 Dec; 282(1-2):303-13. PubMed ID: 21762764
[TBL] [Abstract][Full Text] [Related]
6. Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.
Leake PA; Stakhovskaya O; Hetherington A; Rebscher SJ; Bonham B
J Assoc Res Otolaryngol; 2013 Apr; 14(2):187-211. PubMed ID: 23392612
[TBL] [Abstract][Full Text] [Related]
7. Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation.
Nadol JB
Otolaryngol Head Neck Surg; 1997 Sep; 117(3 Pt 1):220-8. PubMed ID: 9334769
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage.
Nakaizumi T; Kawamoto K; Minoda R; Raphael Y
Audiol Neurootol; 2004; 9(3):135-43. PubMed ID: 15084818
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophin Gene Therapy in Deafened Ears with Cochlear Implants: Long-term Effects on Nerve Survival and Functional Measures.
Pfingst BE; Colesa DJ; Swiderski DL; Hughes AP; Strahl SB; Sinan M; Raphael Y
J Assoc Res Otolaryngol; 2017 Dec; 18(6):731-750. PubMed ID: 28776202
[TBL] [Abstract][Full Text] [Related]
10. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs.
Agterberg MJ; Versnel H; van Dijk LM; de Groot JC; Klis SF
J Assoc Res Otolaryngol; 2009 Sep; 10(3):355-67. PubMed ID: 19365690
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons.
Chikar JA; Colesa DJ; Swiderski DL; Di Polo A; Raphael Y; Pfingst BE
Hear Res; 2008 Nov; 245(1-2):24-34. PubMed ID: 18768155
[TBL] [Abstract][Full Text] [Related]
12. AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.
Leake PA; Rebscher SJ; Dore' C; Akil O
J Assoc Res Otolaryngol; 2019 Aug; 20(4):341-361. PubMed ID: 31222416
[TBL] [Abstract][Full Text] [Related]
13. Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear.
Pinyon JL; Tadros SF; Froud KE; Y Wong AC; Tompson IT; Crawford EN; Ko M; Morris R; Klugmann M; Housley GD
Sci Transl Med; 2014 Apr; 6(233):233ra54. PubMed ID: 24760189
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of AAV.BDNF and AAV.Ntf3 in the deafened adult guinea pig ear.
Budenz CL; Wong HT; Swiderski DL; Shibata SB; Pfingst BE; Raphael Y
Sci Rep; 2015 Mar; 5():8619. PubMed ID: 25726967
[TBL] [Abstract][Full Text] [Related]
15. Temporary Neurotrophin Treatment Prevents Deafness-Induced Auditory Nerve Degeneration and Preserves Function.
Ramekers D; Versnel H; Strahl SB; Klis SF; Grolman W
J Neurosci; 2015 Sep; 35(36):12331-45. PubMed ID: 26354903
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophic effects of GM1 ganglioside and electrical stimulation on cochlear spiral ganglion neurons in cats deafened as neonates.
Leake PA; Hradek GT; Vollmer M; Rebscher SJ
J Comp Neurol; 2007 Apr; 501(6):837-53. PubMed ID: 17311311
[TBL] [Abstract][Full Text] [Related]
17. Estimating health of the implanted cochlea using psychophysical strength-duration functions and electrode configuration.
Garadat SN; Colesa DJ; Swiderski DL; Raphael Y; Pfingst BE
Hear Res; 2022 Feb; 414():108404. PubMed ID: 34883366
[TBL] [Abstract][Full Text] [Related]
18. Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
McGuinness SL; Shepherd RK
Otol Neurotol; 2005 Sep; 26(5):1064-72. PubMed ID: 16151360
[TBL] [Abstract][Full Text] [Related]
19. The peripheral processes of spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs.
Waaijer L; Klis SF; Ramekers D; Van Deurzen MH; Hendriksen FG; Grolman W
Otol Neurotol; 2013 Apr; 34(3):570-8. PubMed ID: 23449444
[TBL] [Abstract][Full Text] [Related]
20. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy.
Yagi M; Kanzaki S; Kawamoto K; Shin B; Shah PP; Magal E; Sheng J; Raphael Y
J Assoc Res Otolaryngol; 2000 Dec; 1(4):315-25. PubMed ID: 11547811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
